Robert Besthof

Chief Comm. & Patient Officer, NRX Pharmaceuticals, Inc.

Companies

NRX Pharmaceuticals, Inc.Chief executive officer Mar 10, 2022 to Mar 10, 2022¹
NRX Pharmaceuticals, Inc.Chief Comm. & Patient Officer Jun 10, 2021 to Nov 2, 2021²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

NRX Pharmaceuticals, Inc. NRXP23,710 shares³$64.3K at $2.71Sep 15, 2021

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 15, 2021Sold 40,000 shares at $11.76 of NRX Pharmaceuticals, Inc.³
Aug 16, 2021Exercised options 63,710 shares at $0.20 of NRX Pharmaceuticals, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNRX Pharmaceuticals, Inc., Chief executive officer
2
SEC EDGARNRX Pharmaceuticals, Inc., Chief Comm. & Patient Officer
3
SEC EDGARNRX Pharmaceuticals, Inc. shares after the filing of Sep 15, 2021